|
Corporate Membership
Letter to the Sponsors from The President - Please click this link
for a .pdf version of the letter
The International
Immunocompromised Host Society (ICHS) has been in existence for over
25 years, and has an active membership of approximately 600 members;
mainly practicing clinicians and researchers. ICHS has been holding
international conferences on Infections in the Immunocompromised Host
every other year, the last meeting was in 2006 was its 14th
international conference. The next symposium will take place on 22-25
June 2008, in Thessaloniki Greece.
Recent initiatives
within the society have included:
-
ICHS consultancy
panels (advisory boards)
-
ICHS Learning
Initiatives. The first of these, the Mycology Initiative, was
launched in 2001; module 3 was recently completed and is now
available to members. Modules 1 and 2 are available to anyone
interested
The ICHS would like
to thank its sponsors and exhibitors for their support over the past
years. Past sponsors include:
|
Abbott
Laboratories |
AstraZeneca |
Aventis |
|
Bayer |
Biotrin |
Bristol-Meyers
Squibb |
|
Chiron |
Cubist |
Fujisawa |
|
Gilead Sciences |
GlaxoSmithKline |
Hoffman-La
Roche |
|
Leo Pharma |
Lilly
Pharmaceuticals |
Merck Inc. |
|
Octapharma |
Ortho-McNeil |
Pfizer
Pharmaceuticals |
|
Pharmacia |
Schering Plough
Inc |
Wyeth
Laboratories |
|
Cephalon |
Cellestis |
|
As you know
sponsors are able to choose which items they support at the biennial
symposium, e.g.: conference bags, suites, lunches, satellites etc on a
first-come-first-served basis. ICHS plans for a new way
of working to give our valued sponsors the opportunity to become
Corporate Members of ICHS. Corporate Members will have priority choice
for such items at future ICHS symposia; in addition we plan to meet
with our Corporate Members in advance of well attended conferences
such as ICAAC and ECCMID to discuss our activities and future plans.
Corporate Members
will join with the ICHS general membership to promote all aspects of
our work with the immunocompromised host. Corporate Members will have
fees to pay, just like general members. Corporate Members will not
have voting rights and cannot hold office, but they will enjoy a range
of benefits depending on their level of commitment.
ICHS proposes two
levels of Corporate Membership, to be paid on the years between
the biennial symposium, i.e. 2007, 2009, 2011 etc.:
Senior
Corporate Member: $50,000
-
Priority right
for exhibition space at biennial meetings
-
Priority right
for satellite sessions at biennial meetings
-
ICHS will provide
6 free registrations to the ICHS biennial meeting
-
Access to
members-only areas of web site
-
Access to the
members mailing list
-
Access to meeting
participants mailing list
-
Early information
on ICHS symposia and other activities
-
Formal access to
council members by email (and phone)
-
Access to ICHS
expertise for development of educational programs (with or without
CME)
-
Formal right to
submit proposal of any kind to the council or general assembly
-
Access to ICHS
expertise through Consultancy panels
-
Input on
potential faculty members to address hot topics
-
Use of ICHS logo
“ICHS Senior Corporate Member”
on company materials related to the immunocompromised area
-
Recognition on
the ICHS website with hyperlink to company site
-
Regular meetings
with ICHS council members, at ICAAC and ECCMID (4 representatives)
Corporate Member: $25,000
-
Second choice for
exhibition space at biennial meetings
-
Second choice for
satellite sessions at biennial meetings
-
ICHS will provide
3 free registrations to the ICHS biennial meeting
-
Access to the
members mailing list
-
Access to meeting
participants mailing list
-
Early information
on all ICHS symposia and other activities
-
Access to ICHS
expertise through Consultancy panels
-
Input on
potential faculty members to address hot topics
-
Access to member
only area of web site
-
Use of ICHS logo
“ICHS Corporate Member”
on company materials related to the immunocompromised area
-
Recognition on
the ICHS website with hyperlink to company site
-
Regular meetings
with ICHS council members, ICAAC, ECCMID (2 representatives)
With your support
we can better serve our membership and friends who attend our
meetings; we will be able to implement more ICHS Consultant Panels and
learning initiatives in other areas (such as sepsis, HIV, the neonate,
etc) and we will be able to attend to the membership responsibilities
and keep the society moving forward for the good of our members and
patients.
Click here to send a form to the
Executive Director
|